Global Pain Management Devices Market Size

1. Global Pain Management Devices Market Size, Share, Growth Analysis, By Product By Application- Industry Forecast 2023-2030 Global Pain Management Devices Market size was valued at USD 6.40 billion in 2021 and is poised to grow from USD 7.0 billion in 2022 to USD 6.42 billion by 2030, at a CAGR of 14.1% during the forecast period (2023- 2030). Global Pain Management Devices Market size was valued at USD 6.40 billion in 2021 and is poised to grow from USD 7.0 billion in 2022 to USD 6.42 billion by 2030, at a CAGR of 14.1% during the forecast period (2023- 2030). The rising incidence of chronic diseases is one of the major factors anticipated to fuel market expansion over the forecast period. Muscle and nerve stimulators are in greater demand due to the rising prevalence of lifestyle diseases including diabetes and obesity. Another significant aspect that could fuel market expansion is the rising incidence of trauma or hypertension. A brain aneurysm and other chronic illnesses are also considerably hypertension. increased by

2. The spread of the risky coronavirus has economic ramifications for almost every industry, including the one that makes medical devices. The state-wide lockout has affected patients who rely heavily on physical therapy or exercise regimens for pain management. Furthermore, a lot of elective surgeries and in-person patient visits have been postponed or cancelled, which is anticipated to increase demand for at-home pain management. Omron expanded its current line of drug- free pain management devices in April 2020 by adding the new Focus TENS Therapy device for the knee. Over the projection period, the number of cancer cases is anticipated to increase further, driving up demand. In addition, the prevalence of musculoskeletal conditions such arthritis, osteoarthritis, orthopaedic degenerative illnesses, and rheumatoid arthritis is rising sharply. Chronic discomfort and the inability to perform daily tasks have become more common in these persons as a result. For instance, the CDC estimates that over 24.5% of American adults had arthritis in 2020, making it the most common cause of job incapacity. To manage chronic pain, this has increased the demand for pain management stimulators. In addition, nearly 32.5 million Americans were expected to have osteoarthritis

3. in 2020. Furthermore, it is projected that technical developments will fuel the market even more. The company's portfolio would dramatically increase as a result. Boston Scientific Corp. completed the acquisition of Baylis Medical Company, Inc. in February 2022. Global Pain Management Devices Market Segmental Analysis The global pain management devices market is segmented based on product, application, and region. In terms of product, the market is segmented into electrical stimulators, radiofrequency ablation (RFA), analgesic infusion pumps, and neurostimulation. With regard to categorization by application, the market is

4. segmented into cancer, neuropathic pain, facial & migraine, musculoskeletal disorder, trauma, and others. Regionwise, the global pain management devices market is widespread into North America, Europe, Asia- Pacific, South America, and MEA. View-More https://www.skyquestt.com/report/pain- management-devices-market Top Player’s Company Profiles in Global Pain Management Devices Market •Abbott Laboratories •Medtronic •Boston Scientific •Pfizer •Johnson & Johnson •Nevro Corporation •Baxter International •St. Jude Medical •B. Braun Melsungen AG •Smiths Medical •Hospira

5. •Endo International •Djo Global •Halyard Health •Stryker Corporation •NeuroMetrix •Avanos Medical •NIPRO Corporation •Terumo Corporation •Stimwave Technologies About Us: SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally. Address: 1 Apache Way, Westford, Massachusetts 01886

6. Phone: USA (+1) 617-230-0741 Email: sales@skyquestt.com LinkedIn Facebook Twitter